Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons

被引:238
作者
Auclair, N
Otani, S
Soubrie, P
Crepel, F
机构
[1] Univ Paris 06 07, Inst Neurosci, Lab Neurobiol & Neuropharmacol Dev, CNRS, F-75252 Paris 05, France
[2] Sanofi Rech, F-34184 Montpellier, France
关键词
D O I
10.1152/jn.2000.83.6.3287
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cannabinoids receptors have been reported to modulate synaptic transmission in many structures of the CNS, but yet little is known about their role in the prefrontal cortex where type I cannabinoid receptor (CB-1) are expressed. In this study, we tested first the acute effects of selective agonists and antagonist of CB-1 on glutamatergic excitatory postsynaptic currents (EPSCs) in slices of rat prefrontal cortex (PFC). EPSCs were evoked in patch-clamped layer V pyramidal cells by stimulation of layer V afferents. Monosynaptic EPSCs were strongly depressed by bath application (1 mu M) of the cannabinoid receptors agonists WIN55212-2 (-50.4 +/- 8.8%) and CP55940 (-42.4 +/- 10.9%). The CB-1 antagonist SR141716A reversed these effects. Unexpectedly, SR141716A alone produced a significant increase of glutamatergic synaptic transmission (+46.9 +/- 11.2%), which could be partly reversed by WIN55212-2. In the presence of strontium in the bath, the frequency but not the amplitude of asynchronous synaptic events evoked in layer V pyramidal cells by stimulating layer V afferents, was markedly decreased (-54.2 +/- 8%), indicating a presynaptic site of action of cannabinoids at these synapses. Tetanic stimulation (100 pulses at 100 Hz, 4 trains) induced in control condition, no changes (n = 7/18), long-term depression (LTD; n = 6/18), or long-term potentiation (LTP; n = 5/18) of monosynaptic EPSCs evoked by stimulation of layer V afferents. When tetanus was applied in the presence of WIN 55,212-2 or SR141716-A (1 mM) in the bath, the proportion of "nonplastic" cells were not significantly changed (n = 7/15 in both cases). For the plastic ones (n = 8 in both cases), WIN 55,212-2 strongly favored LTD (n = 7/8) at the apparent expense of LTP (n = 1/8), whereas the opposite effect was observed with SR141716-A (7/8 LTP; 1/8 LTD). These results demonstrate that cannabinoids influence glutamatergic synaptic transmission and plasticity in the PFC of rodent.
引用
收藏
页码:3287 / 3293
页数:7
相关论文
共 47 条
  • [1] NEUROBIOLOGY OF MARIJUANA ABUSE
    ABOOD, ME
    MARTIN, BR
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (05) : 201 - 206
  • [2] AGGLETON JP, 1995, J NEUROSCI, V15, P7270
  • [3] AUTOMATIC DETECTION OF SPONTANEOUS SYNAPTIC RESPONSES IN CENTRAL NEURONS
    ANKRI, N
    LEGENDRE, P
    FABER, DS
    KORN, H
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 1994, 52 (01) : 87 - 100
  • [4] CANNABINOID RECEPTORS AND MODULATION OF CYCLIC-AMP ACCUMULATION IN THE RAT-BRAIN
    BIDAUTRUSSELL, M
    DEVANE, WA
    HOWLETT, AC
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 55 (01) : 21 - 26
  • [5] THEORY FOR THE DEVELOPMENT OF NEURON SELECTIVITY - ORIENTATION SPECIFICITY AND BINOCULAR INTERACTION IN VISUAL-CORTEX
    BIENENSTOCK, EL
    COOPER, LN
    MUNRO, PW
    [J]. JOURNAL OF NEUROSCIENCE, 1982, 2 (01) : 32 - 48
  • [6] A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 - Evidence for a new model of receptor/ligand interactions
    Bouaboula, M
    Perrachon, S
    Milligan, L
    Canat, X
    RinaldiCarmona, M
    Portier, M
    Barth, F
    Calandra, B
    Pecceu, F
    Lupker, J
    Maffrand, JP
    LeFur, G
    Casellas, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) : 22330 - 22339
  • [7] Role of cyclic AMP in the actions of cannabinoid receptors
    Childers, SR
    Deadwyler, SA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1996, 52 (06) : 819 - 827
  • [8] PREVENTION BY THE CANNABINOID ANTAGONIST, SR141716A, OF CANNABINOID-MEDIATED BLOCKADE OF LONG-TERM POTENTIATION IN THE RAT HIPPOCAMPAL SLICE
    COLLINS, DR
    PERTWEE, RG
    DAVIES, SN
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (06) : 869 - 870
  • [9] DEADWYLER SA, 1993, RECEPTOR CHANNEL, V1, P121
  • [10] DEVANE WA, 1988, MOL PHARMACOL, V34, P605